Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFα

Annals of the Rheumatic Diseases

Volumn 60, Issue 8, 2001, Pages 750-755

  Baeten, D ^a   Van Damme, N ^a   Van den Bosch, F ^a   Kruithof, E ^a   De Vos, M ^b   Mielants, H ^a   Veys, E M ^a   De Keyser, F ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b Department of Gastroenterology ^*  (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INFLIXIMAB; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MALE; MONONUCLEAR CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; SPONDYLOARTHROPATHY; T LYMPHOCYTE; TH1 CELL;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; FLOW CYTOMETRY; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-4; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; SPINAL DISEASES; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES; TH1 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034941556     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.60.8.750     Document Type: Article

References (42)

1. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties
2. Functional diversity of helper T lymphocytes
3. Cytokines and arthritis: Is the Th1/Th2 paradigm useful for understanding pathogenesis?
4. Th1/Th2 cytokine balance in arthritis
5. IL-10 plasma levels correlate with disease activity in spondyloarthropathy
6. Crucial role of interleukin-10/interleukin-12 balance in the regulation of the type 2 T helper cytokine response in reactive arthritis
7. T cell cytokines in gut mucosa of patients with spondyloarthropathy reflect immune alterations in Crohn's disease
8. Evidence for a different cytokine secretion pattern of peripheral blood mononuclear cells of HLA B27+ patients with ankylosing spondylitis and HLA B27+ healthy controls compared to HLA B27 negative controls
9. Contrasting cytokine profiles in the synovium of different forms of juvenile rheumatoid arthritis and juvenile spondyloarthropathy: Prominence of interleukin 4 in restricted disease
10. Differential Th1/Th2 cytokine patterns in chronic arthritis: Interferon γ is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies
11. The elevated ratio of interferon gamma-/interleukin-4-positive T cells found in synovial fluid and synovial membrane of rheumatoid arthritis patients can be changed by interleukin-4 but not by interleukin-10 or transforming growth factor beta
12. Effects of a loading dose regimen of 3 infusions of chimeric monoclonal antibody to tumor necrosis factor α (infliximab) in spondyloarthropathy: An open pilot study
13. Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis
14. Anti-tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo
15. Long-term follow-up of the changes in circulating cytokines, soluble cytokine receptors, and white blood cell subset counts in patients with rheumatoid arthritis (RA) after monoclonal anti-TNF alpha antibody therapy
16. Treatment with monoclonal anti-tumor necrosis factor α antibody results in an accumulation of Th1 CD4+ T cells in the peripheral blood of patients with rheumatoid arthritis
17. V alpha 14+ NK T cells: A novel lymphoid cell lineage with regulatory function
18. Natural killer T cells: A potent cytokine-producing cell population
19. The European Spondyloarthropathy Study Group preliminary criteria for the classification of spondyloarthropathy
20. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
21. Decreased peripheral blood T cell cytokine gene expression in rheumatoid arthritis
22. Flow cytometric detection of type 1 (IL-2, IFN-gamma) and type 2 (IL-4, IL-5) cytokines in T-helper and T-suppressor/cytotoxic cells in rheumatoid arthritis, allergic asthma and atopic dermatitis
23. Production, tissue distribution and function of IL-10 in psoriatic synovium
24. High level of interleukin-10 production by the activated T cell population within the rheumatoid synovial membrane
25. Elevated interleukin-10 levels in patients with rheumatoid arthritis
26. Selective reduction of V alpha 14+ NK T cells associated with disease development in autoimmune-prone mice
27. Diabetes prone BB rats are severely deficient in natural killer T cells
28. Differential expression of NK T cell V alpha 24J alpha Q invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy
29. Increased interleukin-4 production by NK T cells in systemic lupus erythematosus
30. Protective role of NK1.1+ cells in experimental Staphylococcus aureus arthritis
31. Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees
32. Interleukin-10 functions as an antiinflammatory cytokine in rheumatoid synovium
33. Antiinflammatory and immunoregulatory action of methotrexate in the treatment of rheumatoid arthritis: Evidence of increased interleukin-4 and interleukin-10 gene expression demonstrated in vitro by competitive reverse transcriptase-polymerase chain reaction
34. Response to methotrexate in early arthritis is associated with a decrease of T cell derived tumour necrosis factor alpha, increase of interleukin 10, and predicted by the initial concentration of interleukin 4
35. IL-12 regulates T helper type 1 cytokine responses in human infectious disease
36. Cytokine patterns in the pathogenesis of human leishmaniasis
37. Low secretion of tumour necrosis factor α, but no other Th1 or Th2 cytokines, by peripheral blood mononuclear cells correlates with chronicity in reactive arthritis
38. Predominance of Th1-type T cells in synovial fluid of patients with Yersinia-induced reactive arthritis
39. Salmonella lipopolysaccharide in synovial cells of patients with reactive arthritis
40. Yersinia antigens in synovial fluid cells from patients with reactive arthritis
41. Detection of Chlamydia trachomatis DNA in joints of reactive arthritis patients by polymerase chain reaction
42. Pathogenesis of spondyloarthropathies: Persistent bacterial antigen, autoimmunity or both?